NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.
复制标题
乳腺癌中的 NOTCH2:SNP rs11249433 与无 TP53 突变的 ER 阳性乳腺肿瘤中基因表达的关联。
DOI:
10.1186/1476-4598-9-113
复制
发表时间:
2010-05-19
期刊:
影响因子:
37.3
通讯作者:
Prokunina-Olsson, Ludmila
中科院分区:
文献类型:
--
作者:
Fu, Yi-Ping;Edvardsen, Hege;Kaushiva, Alpana;Arhancet, Juan P.;Howe, Tiffany M.;Kohaar, Indu;Porter-Gill, Patricia;Shah, Anushi;Landmark-Hoyvik, Hege;Fossa, Sophie D.;Ambs, Stefan;Naume, Bjorn;Borresen-Dale, Anne-Lise;Kristensen, Vessela N.;Prokunina-Olsson, Ludmila
A recent genome-wide association study (GWAS) has identified a single nucleotide polymorphism (SNP) rs11249433 in the 1p11.2 region as a novel genetic risk factor for breast cancer, and this association was stronger in patients with estrogen receptor (ER)+ versus ER- cancer. We found association between SNP rs11249433 and expression of the NOTCH2 gene located in the 1p11.2 region. Examined in 180 breast tumors, the expression of NOTCH2 was found to be lowest in tumors with TP53 mutations and highest in TP53 wild-type/ER+ tumors (p = 0.0059). In the latter group, the NOTCH2 expression was particularly increased in carriers of the risk genotypes (AG/GG) of rs11249433 when compared to the non-risk AA genotype (p = 0.0062). Similar association between NOTCH2 expression and rs11249433 was observed in 60 samples of purified monocytes from healthy controls (p = 0.015), but not in total blood samples from 302 breast cancer patients and 76 normal breast tissue samples. We also identified the first possible dominant-negative form of NOTCH2, a truncated version of NOTCH2 consisting of only the extracellular domain. This is the first study to show that the expression of NOTCH2 differs in subgroups of breast tumors and by genotypes of the breast cancer-associated SNP rs11249433. The NOTCH pathway has key functions in stem cell differentiation of ER+ luminal cells in the breast. Therefore, increased expression of NOTCH2 in carriers of rs11249433 may promote development of ER+ luminal tumors. Further studies are needed to investigate possible mechanisms of regulation of NOTCH2 expression by rs11249433 and the role of NOTCH2 splicing forms in breast cancer development.
登录
查看更多内容
影响因子:
23.9
作者:
Bouras, Toula;Pal, Bhupinder;Visvader, Jane E.
通讯作者:
Visvader, Jane E.
影响因子:
4.2
作者:
Hirose, Hajime;Ishii, Hideshi;Mori, Masaki
通讯作者:
Mori, Masaki
影响因子:
39.2
作者:
LI, FP;FRAUMENI, JF
通讯作者:
FRAUMENI, JF
DOI:
10.1186/bcr1675
发表时间:
2007
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Langerød A;Zhao H;Borgan Ø;Nesland JM;Bukholm IR;Ikdahl T;Kåresen R;Børresen-Dale AL;Jeffrey SS
通讯作者:
Jeffrey SS
影响因子:
4.5
作者:
Jia L;Landan G;Pomerantz M;Jaschek R;Herman P;Reich D;Yan C;Khalid O;Kantoff P;Oh W;Manak JR;Berman BP;Henderson BE;Frenkel B;Haiman CA;Freedman M;Tanay A;Coetzee GA
通讯作者:
Coetzee GA